News

Dr Reddy’s–Alvotech deal: Why investors are bullish
CHENNAI: Shares of Dr Reddy’s Laboratories surged over 3% in early trade on Thursday after the Indian drug maker announced a ...
News-Medical.Net on MSN1d
SWOG S2302 Pragmatica-Lung study demonstrates value of streamlined clinical trials in real world settings
The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...
Good News Network3d
Grandfather Diagnosed With Stage Four Lung Cancer Becomes Free of Disease After Immunotherapy
A grandad diagnosed with stage 4 lung cancer–one of the deadliest—has become disease-free after being treated with an ...
CNBCTV182h
Dr. Reddy's Laboratories shares rise after collaboration with Alvotech to make cancer treatment drug
Under the agreement signed between the two companies, Alvotech and Dr. Reddy’s will be jointly responsible for developing and ...
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...
EurekAlert!2d
S2302 Pragmatica-Lung reports out as model for faster, leaner, more representative trials
The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad eligibility criteria, and reduced data collection, has quickly answered its primary ...
BlackDoctor.org1d
Game-Changing Cancer Breakthroughs Could Improve Health Outcomes for Black Communities
New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...
Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy
Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and develop the latter's ...